Upgrade to SI Premium - Free Trial

Biogen (BIIB) PT Raised to $350 at Canaccord Genuity Ahead of 4Q17 Earnings Announcement on 1/25 BMO; 'Lower Tax Rate in 2018+ Main Driver'

January 24, 2018 12:01 PM
Canaccord Genuity raised its price target on Biogen (NASDAQ: BIIB) to $350.00 (from $340.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles